Magazine Article | April 30, 2012

Fostering Asian Collaborations For Pharma Innovations

Source: Life Science Leader

By Gail Dutton, Contributing Writer
Follow Me On Twitter @GailLdutton

Astrazeneca’s collaboration with Asia extends their opportunity in pharmaceutical R&D and commercialization, because Asia lacks the entrenched drug development bureaucracy, which provides a relatively clean slate for pharma innovation. By Gail Dutton, contributing editor